Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension

Lupin Mexiletine Hydrochloride gets Orphan Drug Designation from USFDA

Ruchika Sharma9 Jun 2020 11:04 AM IST

Mexiletine reduces myotonia symptoms, resulting in a significant improvement in patient quality-of-life and other functional outcomes

Marksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian markets

Marksans Pharma recalls Metformin ER Tablets over probable carcinogen

Ruchika Sharma9 Jun 2020 10:30 AM IST

Metformin extended release tablets are indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes...

Biocon Chief Kiran Shaw wins EY World Entrepreneur of the Year 2020 Award

Ruchika Sharma7 Jun 2020 10:45 AM IST

In the award's 20-year history, Mazumdar-Shaw is the first woman entrepreneur from India and the third Indian to win it

Lyka Labs faces liquidity crunch, sales affected due to COVID restrictions

Ruchika Sharma7 Jun 2020 10:30 AM IST

In a regulatory filing disclosing the impact of COVID-19, Lyka Labs said although the government allowed pharma firms to operate during the lockdown,...

Portea Medical, Delhi Govt join hands for home isolation services for COVID-19 patients

Ruchika Sharma7 Jun 2020 10:15 AM IST

As more than 80 percent of COVID-19 patients are asymptomatic or have mild symptoms and do not require hospital care, the company has been helping the...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

UK vaccine summit raises USD 8.8 billion for immunization

Ruchika Sharma7 Jun 2020 10:00 AM IST

Thursday's event, which raised $8.8 billion, exceeding its target, was a pledging conference for the vaccines alliance GAVI, which says the funds will...

Ayurvedic Drug For COVID-19: Dalmia Healthcare starts clinical trials of polyherbal combo Astha-15

Ruchika Sharma7 Jun 2020 9:45 AM IST

As per the study, the drug acts as a bronchodilator, decongestant, anti-inflammatory, lung detoxifier and did not show any side-effects, it added

Aurobindo Pharma Q4 net profit up by 45pc to Rs 850 crore

Ruchika Sharma7 Jun 2020 9:30 AM IST

The net profit, after JV share and minority interest, jumped by 19.7 percent to ₹2,831 crore as against ₹2,364. 7 crore in FY '19. Managing director...

DocsApp, MediBuddy merge to expand digital platform, raise around Rs 150 crore funding

Ruchika Sharma6 Jun 2020 4:42 PM IST

The merged entity has raised USD 20 million (around Rs 150 crore) in Series B round of funding led by Bessemer Venture Partners, Fusian Capital,...

PM Modi pledges over Rs 113 crore to global vaccines alliance GAVI

Ruchika Sharma6 Jun 2020 12:54 PM IST

Addressing the summit, Prime Minister Modi said, "Our support to Gavi is not only financial. India's huge demand brings down the global price of...

Zydus Cadila gets final USFDA nod to HIV infection drug Atazanavir

Ruchika Sharma6 Jun 2020 11:29 AM IST

Atazanavir, an antiretroviral drug, is used to treat infection of the Human Immunodeficiency Virus (HIV)

UK terms Hydroxychloroquine for COVID-19 patients as useless, halts trial

Ruchika Sharma6 Jun 2020 10:00 AM IST

"This is not a treatment for COVID-19. It doesn't work," Martin Landray, an Oxford University professor who is co-leading the RECOVERY trial, told...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok